Insider Profile
Hamer, Andrew Warwick
1
Companies Filed At
1
Open-Market Buys (2yr)
$25K
Buy Value (2yr, open-market)
Dec 03, 2025
Most Recent Trade
9
Credibility
Score
9%
Hit Rate
-7.7%
Avg 90d Return
-9.5%
Median 90d Return
11
Evaluated Trades
+87.1%
Best Trade
-51.8%
Worst Trade
Hit rate and returns are based on 11 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Dec 03, 2025 $CRDL
Cardiol Therapeutics Inc
Comp. Grant Buy 250,000 $1.00 $250K 45
Dec 03, 2025 $CRDL
Cardiol Therapeutics Inc
Comp. Grant Buy 250,000 $1.00 $250K 45
Oct 01, 2025 $CRDL
Cardiol Therapeutics Inc
Exercise Buy 133,334 45
Oct 01, 2025 $CRDL
Cardiol Therapeutics Inc
Exercise Sell 133,334 45
Sep 08, 2025 $CRDL
Cardiol Therapeutics Inc
Exercise Buy 70,000 45
Sep 08, 2025 $CRDL
Cardiol Therapeutics Inc
Exercise Sell 70,000 45
Dec 19, 2024 $CRDL
Cardiol Therapeutics Inc
Open Market Buy 18,900 $1.31 $25K 45
Sep 06, 2024 $CRDL
Cardiol Therapeutics Inc
Exercise Buy 75,000 45
Sep 06, 2024 $CRDL
Cardiol Therapeutics Inc
Exercise Sell 75,000 45
Jul 10, 2024 $CRDL
Cardiol Therapeutics Inc
Comp. Grant Buy 285,000 45
Nov 29, 2023 $CRDL
Cardiol Therapeutics Inc
Exercise Sell 133,333 45
Nov 29, 2023 $CRDL
Cardiol Therapeutics Inc
Exercise Buy 133,333 45
Dec 30, 2022 $CRDL
Cardiol Therapeutics Inc
Exercise Sell 6,047 45
Dec 30, 2022 $CRDL
Cardiol Therapeutics Inc
Comp. Grant Buy 6,047 45
Dec 30, 2022 $CRDL
Cardiol Therapeutics Inc
Exercise Buy 6,047 45
Sep 30, 2022 $CRDL
Cardiol Therapeutics Inc
Comp. Grant Buy 400,000 $1.41 $564K 45
Sep 30, 2022 $CRDL
Cardiol Therapeutics Inc
Expiry Sell 400,000 45
Apr 12, 2021 $CRDL
Cardiol Therapeutics Inc
Other Buy 100,000 $4.23 $423K 45
Mar 30, 2021 $CRDL
Cardiol Therapeutics Inc
Comp. Grant Buy 400,000 $4.51 $1.8M 45
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.